Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.06.10.731458

A Computational Framework for Extracting Mechanistic Hypotheses from Quantitative Data of Morphological Dynamics

Abstract

Advances in live-cell imaging and image analysis have made it possible to quantitatively measure the spatiotemporal morphological dynamics of biological phenomena at scale. However, a general framework is still lacking for systematically extracting, from the resulting multivariate data, which relationships between phenotypic characters are mechanistically interpretable and which gene perturbations disrupt those relationships. Here, we propose a computational framework for extracting mechanistic hypotheses and candidate genes from quantitative data of morphological dynamics. First, we detect reproducible correlations between phenotypic characters in wild-type data and interpret them as mechanistic hypotheses in light of existing knowledge. Next, we perform outlier analysis on data obtained under gene perturbation and extract, as candidates, genes that selectively disrupt relationships between phenotypic characters maintained in the wild type. We further integrate the extracted relationships into a spatiotemporal network to provide an overview of how phenotypic characters are linked across the developmental process. As a proof of concept, we applied the framework to quantitative data on nuclear division dynamics during early embryogenesis in Caenorhabditis elegans and recovered relationships between phenotypic characters consistent with known mechanisms while prioritizing candidate genes. This framework provides a useful basis for efficiently generating testable mechanistic hypotheses from quantitative data of morphological dynamics. Author SummaryHow does a single cell give rise to a complex organism? Answering this question requires understanding not only which genes are active, but how the physical behavior of cells--their shapes, positions, and movements--is coordinated across time and space. Live-cell imaging now allows researchers to measure these morphological dynamics in quantitative detail, yet extracting biological meaning from the resulting large, high-dimensional datasets remains a challenge. Here we present a computational framework that addresses this challenge by treating correlations between quantitative morphological measurements as windows into the underlying biological machinery. Applied to the nematode Caenorhabditis elegans, a powerful model organism whose early development is exquisitely reproducible, our approach automatically identifies pairs of cellular measurements that reliably co-vary in normal embryos and interprets these relationships as reflecting shared biological mechanisms. When genes are inactivated one at a time and the resulting embryos deviate from the expected co-variation, those genes are flagged as candidates for the disrupted mechanism. In a systematic test using embryos in which 263 genes had been individually inactivated, the framework correctly prioritized genes with known roles in spindle positioning and cell polarity. By converting large-scale morphodynamic datasets into a network of testable mechanistic hypotheses, this framework offers a broadly applicable strategy for moving from quantitative phenotyping to mechanistic understanding across diverse biological systems.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kyoda, K., Okada, H., Onami, S.. 2026-06-15. A Computational Framework for Extracting Mechanistic Hypotheses from Quantitative Data of Morphological Dynamics. https://doi.org/10.64898/2026.06.10.731458

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Personalized Immunotherapy via Multiscale Tumor-Immune Modeling and Optimal Control

Cancer remains a global health challenge requiring sophisticated understanding of tumor-immune dynamics for effective treatment design. Mathematical oncology has emerged as a rapidly evolving interdisciplinary field that uses mathematical models to enhance our understanding of cancer dynamics, including tumor growth, metastasis, and treatment response. This paper presents a comprehensive multiscale framework integrating patient-specific data, machine learning, and optimal control for personalized immunotherapy design. We develop a hybrid model that combines deterministic dynamics with stochastic elements and time delays, capturing the inherent variability and temporal lags in biological processes. The model incorporates biologically realistic Holling Type-II functional responses and is validated against longitudinal clinical data from 100+ cancer patients and patient-derived organoid experiments. Using deep neural networks with Bayesian regularization, we learn patient-specific parameter distributions from clinical biomarkers and predict treatment responses with high accuracy. Our optimal control framework, incorporating clinical constraints and toxicity limits, generates personalized treatment protocols that stabilize otherwise unstable dynamics. The framework establishes a new paradigm for precision immuno-oncology, bridging mathematical theory, computational methods, and clinical practice. Author summaryCancer remains one of the leading causes of death worldwide, and the immune system plays a crucial role in controlling tumor growth. However, the complex interactions between tumor cells and immune cells make it difficult to predict how individual patients will respond to immunotherapy. In this work, we develop a mathematical framework that integrates patient-specific data, machine learning, and optimal control to design personalized immunotherapy strategies. Our model captures the realistic dynamics of tumor-immune interactions by incorporating biologically relevant features such as time delays (representing immune response lags) and stochastic effects (representing biological variability). Using deep learning, we estimate patient-specific parameters from clinical biomarkers, enabling personalized predictions of treatment outcomes. We validate our framework against data from over 100 cancer patients and patient-derived organoid experiments, demonstrating excellent agreement. Our optimal control approach generates personalized treatment protocols that stabilize otherwise unstable tumor dynamics, achieving 78% tumor reduction compared to 52% for standard-of-care protocols. These findings suggest that therapies targeting immunological thresholds may be as important as those directly killing tumor cells, providing a new perspective for immunotherapy design. This framework bridges mathematical theory, computational methods, and clinical practice, offering a pathway toward truly personalized cancer treatment.

Systems Biology↗

Reversible Opto-Chemical activation of KRASG12V signaling with near single-cell precision

KRAS mutations drive some of the most lethal carcinomas, and genomic and inducible systems have established many of the cellular and tissue-level consequences. However, these approaches operate at the level of oncogene expression, allowing for cellular adaptation that masks the individual role of KRAS oncoprotein signaling. Here, we developed a reversible Opto-Chemical system to activate KRAS signaling by chemically translocating a cytosolic mutant KRASG12V G-domain to the plasma membrane upon light or small-molecule input. In MDCK cells, the G-domain plasma membrane recruitment activated downstream signaling and reduced collective migration. In mouse small Intestinal Organoids, G-domain recruitment promoted increased crypt size and number under Epidermal Growth Factor-deprived conditions. We further showed that the increased number of crypts depended on continuous KRASG12V signaling. Finally, under the same deprived conditions, localized activation in just one budding crypt promoted crypt formation compared to controls. This system decouples oncoprotein activity from oncogene expression, allowing to investigate the KRAS signaling contribution to early epithelial transformation.

Systems Biology↗

Mammalian aging involves genome-wide splicing degeneration leading to functional decline

Alternative splicing exhibits significant changes during development and aging, affecting the composition and variance in the transcriptome. However, it is unclear whether and how age-associated splicing dysregulation leads to functional consequences. Here, an integrative analysis of transcriptome data across mouse and human tissues revealed that aging is characterized by systematic deterioration of the fidelity of RNA splicing, here termed splicing degeneration, a measure of functional alteration of reading frame and domain configuration of protein products. Genes with higher aging-associated splicing degeneration were more conserved and enriched for processes such as RNA metabolism and antigen presentation. By assessing alternative splicing events associated with functional deterioration, we quantified the degree of splicing degeneration. Its level increased with age but was alleviated following calorie restriction or rapamycin treatment, indicating that it can serve as a new molecular hallmark of aging. Mechanistically, through a comprehensive meta-data analysis, we discovered that splicing degeneration is associated with age-associated changes in specific splicing factors, which in turn showed a strong association with age-related transcriptome changes. Overall, our study demonstrates the intricate relationship between aging and genome-wide splicing degeneration, revealing a promising target for aging interventions acting to reverse splicing degeneration.

Systems Biology↗